Image (97106093 2f0a 4cc9 B580 942b015c6c5b 01)
Chlorpromazine Hydrochloride Injection
Product Images NDC 70710-1849
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Chlorpromazine Hydrochloride (NDC 70710-1849). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Zydus Pharmaceuticals Usa Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
1ml Container (97106093 2f0a 4cc9 B580 942b015c6c5b 02)
1ml Carton (97106093 2f0a 4cc9 B580 942b015c6c5b 03)
This is a description of a pharmaceutical product, Chlorpromazine Hydrochloride Injection, USP, intended for deep intramuscular use. Each mL contains chlorpromazine hydrochloride USP, 25 mg, ascorbic acid 2 mg, sodium metabisulfite 1 mg, sodium sulfite 1 mg, and sodium chloride 6 mg in water for injection. The usual dosage instructions are provided in the package insert. It is important to protect the product from light and keep it covered in the carton until use. Storage conditions include 20°C to 25°C (68°F to 77°F) with excursions permitted to 15°C to 30°C (59°F to 86°F) to avoid freezing. The product information includes details on substrate, special instructions, and form of supply. The manufacturing details indicate it is made by Zydus Lifesciences Ltd and distributed by Zydus Pharmaceuticals (USA) Inc. *
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
